Form 8-K - Current report:
SEC Accession No. 0000200406-23-000032
Filing Date
2023-04-03
Accepted
2023-03-31 19:29:04
Documents
13
Period of Report
2023-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20230331.htm   iXBRL 8-K 34053
  Complete submission text file 0000200406-23-000032.txt   221069

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20230331.xsd EX-101.SCH 3326
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20230331_def.xml EX-101.DEF 16756
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20230331_lab.xml EX-101.LAB 34197
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20230331_pre.xml EX-101.PRE 17558
7 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20230331_htm.xml XML 8586
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 23789907
SIC: 2834 Pharmaceutical Preparations